Navigation Links
Amgen's Second Quarter 2013 Revenues Increased 5 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 3 Percent To $1.89
Date:7/30/2013

ent and future products, sales growth of recently launched products, competition from other products (domestic or foreign), and difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement.  Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products.  Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities.  We or others could identify safety, side effects or manufacturing problems with our products after they are on the market.  Our business may be impacted by government investigations, litigation and product liability claims.  If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions.  Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new pr
'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
2. Oncology remains most restrictive specialty for second year
3. China Biologic Products to Report Second Quarter 2013 Financial Results
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2013 Second Quarter Financial Results
5. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
6. Webcast Alert: Isis Pharmaceuticals Second Quarter 2013 Financial Results Conference Call
7. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
8. Luminex Corporation Reports Second Quarter 2013 Results
9. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
10. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
11. PDI, Inc. to Hold Second Quarter 2013 Financial Results Conference Call on Monday, August 5, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... WARSAW, Ind. , Nov. 18, 2014  Zimmer ... that it has agreed with the European Commission (the ... of Zimmer,s proposed acquisition of Biomet by a limited ... with certain additional information. Deadline extensions ... been working closely with the regulatory authorities to facilitate ...
(Date:11/18/2014)... 2014  Cardica, Inc. (Nasdaq: CRDC ... approved management,s recommendation to shift Cardica,s primary focus ... XCHANGE® 30 surgical stapler to improving its performance ... result, Cardica has temporarily suspended the controlled commercial ... of the MicroCutter XCHANGE 30 surgical stapler from ...
(Date:11/18/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Monday, December 8, 2014 at 9:00 a.m. Eastern Time to ... th American Society of Hematology Annual Meeting and Exposition.  ... by dialing 877-443-5662 or access the webcast at www.isispharm.com ... time at the same address. ABOUT ISIS ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3
... May 26, 2011 Kensey Nash Corporation (Nasdaq: ... Global Healthcare Conference at The Grand Hyatt in New York, ... Kaufmann, Kensey Nash,s President and CEO, will deliver the Company,s ... live webcast of the Kensey Nash presentation, go to ...
... Pa., May 26, 2011 ViroPharma Incorporated (NASDAQ: ... Swell , a twenty-five minute film that allows families dealing ... share the challenges and triumphs of living with a chronic ... HAE, often times through many generations of the same family. ...
Cached Medicine Technology:ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 2ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 3
(Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
(Date:11/18/2014)... 2014 Recently, Wigsbuy has introduced its ... are offered at greatly discounted prices now, up to 85% ... of human hair products, offering many real and synthetic hair ... global customers, Wigsbuy uses high quality materials to make its ... with the trend. , “We are offering a full ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
(Date:11/18/2014)... By Dennis Thompson HealthDay ... doctor from Sierra Leone who became infected with Ebola in his ... Dr. Martin Salia had arrived Saturday at Nebraska Medical Center ... at a hospital in Sierra Leone,s capital city of Freetown. ... that have been ravaged by the Ebola outbreak that began last ...
(Date:11/17/2014)... 17, 2014 A Diet Doc ... throughout the country are turning back the clock on ... This is because the company has recently added their ... impressive collection of prescription and non-prescription diet products and ... Diet Doc’s best anti-aging human growth hormone ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:It Is The Most Wonderful Time To Buy Full Lace Wigs At Wigsbuy.com 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3
... Lower pay, fewer marriages among those who had depression, ... 17 (HealthDay News) -- Children who experience psychological disorders ... headed for a financially depressed adulthood, new research suggests. ... are less likely to get married or maximize their ...
... ... Village at ProprietorsGreen, a luxury senior rental community developed by Norwell-based ... has opened in Marshfield, Massachusetts. Despite an economic climate that ... on schedule, and opened with 40 percent of its independent living ...
... ... provider of solutions for the workers, compensation and liability markets, announced that it has ... drug requirements pertaining to Medicare Set-Asides (MSA). , ... Tampa, Florida (Vocus) May 17, 2010 -- PMSI ...
... diseases in middle age, despite an absence of family history ... blame, according to a new study conducted by researchers at ... the National Institutes of Health. The study also ... help identify those genetic abnormalities and allow detection before the ...
... the Queensland Institute of Medical Research (QIMR) and the Royal ... successfully treated it by performing an experimental stem cell transplant. ... out of hospital Katie Pulling had almost given up hope. ... the doctors say, ,We don,t know what is wrong, ,We ...
... ... for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very own Torque ... (PRWEB) ... know what to look for. A torque screwdriver comes in many different variations, including ...
Cached Medicine News:Health News:Kids' Psychological Problems Have Long-Term Effects 2Health News:Village at Proprietors Green Opens on South Shore, Introducing Innovative Senior Living to Boston Area 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 3Health News:Lung disease may be genetic, despite lack of family history 2Health News:Australian researchers identify a new disease 2Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: